Pei-Chen Tsai

Pei-Chen Tsai

Auto-generated profile, based on publicly available information

Pei-Chen Tsai

Department of Biomedical Informatics, Harvard Medical School, Boston, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
PTPei-Chen Tsai
Pei-Chen Tsai
TLTsung-Hua Lee
Tsung-Hua Lee
KKKun-Chi Kuo
Kun-Chi Kuo
FSFang-Yi Su
Fang-Yi Su
TLTsung-Lu Michael Lee
Tsung-Lu Michael Lee
KYKun-Hsing Yu
Kun-Hsing Yu
Histopathologic assessment is indispensable for diagnosing colorectal cancer (CRC). However, manual evaluation of the diseased tissues under the microscope cannot reliably inform patient prognosis or genomic variations crucial for treatment selections. To address these challenges, we develop the Multi-omics Multi-cohort Assessment (MOMA) platform, an explainable machine learning approach, to systematically identify and interpret the relationship between patients’ histologic patterns, multi-omics, and clinical profiles in three large patient cohorts (n = 1888). MOMA successfully predicts the overall survival, disease-free survival (log-rank test P-value<0.05), and copy number alterations of CRC patients. In addition, our approaches identify interpretable pathology patterns predictive of gene expression profiles, microsatellite instability status, and clinically actionable genetic alterations. We show that MOMA models are generalizable to multiple patient populations with different demographic compositions and pathology images collected from distinctive digitization methods. Our machine learning approaches provide clinically actionable predictions that could inform treatments for colorectal cancer patients.